Part 1. Biophysical model of HI

Motivation for the model
Presently, there is a paucity of reliable quantitative information about the biophysical determinants of titers. More specifically, there is inadequate knowledge about the manner in which both antigenic and non-antigenic parameters contribute to titers. Such knowledge would not only allow comparisons of titers obtained under different experimental conditions (e.g., using different concentrations of virus and of red cell), it would also enable critical examination of existing approaches to interpreting titers. While there are computational methods for inferring antigenic relationships from titers [1] , to our knowledge there has been only one serious attempt [2] at shedding light on the nature of the biophysical interactions that determine these titers. In particular, Lanni and Lanni [2] investigated the kinetics of HI and derived mathematical 2 equations for the dynamics of the concentration of, for example, virus-antibody and virus-red cell complexes. However, those authors did not derive an equation for the titer. Here, such an equation is derived. The approach presented here differs from that of Lanni and Lanni in important ways. Firstly, an equilibrium (as opposed to a non equilibrium) chemical kinetic framework is used, which is motivated by previous experimental results [3] [4] [5] [6] [7] suggesting that the virus-antibody and virus-red cell interactions that underlie HI are similar in nature to more general enzyme-substrate interactions, and that those HI interactions can attain the equilibrium state 1 on time scales that are typical of the HI assay. Secondly, a collision theory [8] approach is employed, allowing virus-antibody and virus-red cell complexes of arbitrary sizes to be accounted for, in contrast to the absolute rate theory approach employed by Lanni and Lanni.
Thirdly, the emphasis is on shedding light on basic aspects of HI; therefore, a smaller number of simplifying assumptions are made concerning the nature of HI.
More specifically, the analyses described here pertain to an HI assay that is designed to quantify the titer of virus X relative to antibody-containing serum (or "antiserum") raised against virus Y, denoted 1 Although the assumption that HI interactions attain equilibrium is consistent with previous experimental results (e.g., see [6] ), it should be noted that the attainment of equilibrium is dependent on the HI assay conditions (e.g., pH, temperature). Moreover, bound influenza viruses can elute from a red cell by cleaving receptors found on the red cell surface [9] . This raises the possibility that as influenza viruses continuously bind to and elute from cell surface receptors, those receptors could eventually become depleted, thereby rendering red cells non-agglutinable [4, 10] .
However, given that there is on the order of a thousand receptors on each red cell surface [11, 12] such loss of agglutinability may occur on time scales (respectively temperatures) that are much longer (respectively higher) than those typical of HI assays [10] .
Preliminaries
The main steps involved in determining the titer of virus X relative to virus Y-derived antiserum are as follows (e.g., see [13] ): Firstly, virus X is propagated in chicken eggs (or in cell culture), yielding a concentrated solution of the virus. Serial 2-fold dilutions of the virus solution are made and a fixed volume of each diluted solution is mixed with a fixed amount of red cells (see Figure S1 ). The virus-red cell mixtures are incubated for a specified amount of time (e.g., 1
hour) and then examined for the occurrence of agglutination, which is characterized by the absence of a "button" at the bottom of the experimental vessel. The highest dilution of the virus solution that elicits marked agglutination of red cells is called the hemagglutination endpoint.
The corresponding amount of virus is denoted by 1 hemagglutinating unit. After determining the hemagglutinating unit of virus X, 10 serial 2-fold dilutions of antiserum obtained from organisms 
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Note that antisera generally contain different populations of antibodies each of which may have a different affinity for the target virus. The measured affinity of antisera for a virus is the average of the affinities of these different antibody populations. In addition, note that the HI assay protocol is similar to protocols for other serological assays, including the more sensitive neutralization assay [13] . The main difference between the protocols for the HI and neutralization assays is that in the latter assay samples taken from equilibrium antibody-virus mixtures are incubated with susceptible target cells (e.g., Mardin-Darby canine kidney cells), and the neutralization titer is defined as the reciprocal of the maximum dilution of antiserum that inhibits infection in at least 50% of the antibody-virus-cell mixtures.
In the following, the various steps of the HI assay described above are explicitly modeled. First, the kinetics of agglutination of red cells by influenza viruses are analyzed, followed by the kinetics of antibody-mediated inhibition of agglutination. Connections to the neutralization assay are subsequently discussed.
Agglutination of red cells by influenza viruses
The surface of each influenza virus contains numerous hemagglutinin (HA) molecules [9, 14] . Each HA molecule contains a specific site (also called a receptor binding site) that can interact with and bind to a cognate sialic acid-containing receptor found on the surface of a red cell. Typically, multiple receptor binding sites found on the surface of a given virus bind to distinct cell surface receptors found on the same red cell surface; each virus-red cell "bond" is multivalent 3 . This multivalency is necessary in order to ensure the stability of a virus-red cell bond since individual receptor binding site-cell surface receptor bonds are very weak, having equilibrium dissociation constants that are on the order of a millimolar [15] . Let a denote the maximum number of red cells that can be bound simultaneously by the same influenza virus (i.e., 3 The formation of the first receptor binding site-cell surface receptor bond between a virus and a red cell brings adjacent receptor binding sites (found on the surface of the virus) and cell surface receptors (found on the surface of the red cell) closer to each other and, hence, facilitates the formation of additional receptor binding site-cell surface receptor bonds. Accordingly, the rate of formation of a multivalent virus-red cell bond would be given approximately by the rate of formation of the first receptor binding site-cell surface receptor bond.
6 the "effective" number of receptor binding sites) 4 and let b denote the maximum number of influenza viruses that can bind simultaneously to the same red cell (i.e., the "effective" number of cell surface receptors). Previous experimental results suggest that a≈2 [16] . Meanwhile, for chicken red cells, experimental estimates of b range from 830 to 1660 [12] . Higher estimates of b (up to 5,000) have been obtained, using influenza B viruses [11] .
As noted earlier, the titer is determined experimentally by observing the pattern of , while the probability that a cell surface receptor of the red cell is unoccupied is given by   bB
. Now, let  denote the probability that during the collision a free receptor binding site will make contact with an unoccupied cell surface receptor, in the proper orientation (i.e., such that steric hindrance is overcome). Based on the Maxwell-Boltzmann distribution of the kinetic energies of the colliding particles a fraction,
, of such properly oriented collisions will result in the formation of a virus-red cell bond, where a E is the activation energy for virus-red cell bond formation. On the other hand, virus-red cell bonds will dissociate at the rate
where d E is the activation energy for dissociation of a virus-red cell bond and f is a preexponential factor (this dissociation rate depends on the activity of the influenza viral 4 The significantly larger size of a red cell compared to that of an influenza virus -the volume of a spherical influenza virus particle, with a diameter of
, is 3 4 and the fraction of agglutinated red cells (i.e., the fraction of red cells bound by a doubly-bound virus) is given by:
Antibody-mediated inhibition of agglutination
Antibodies recognize and bind to specific antigenic sites of HA molecules found on the influenza viral surface. Theoretical interpretations [5, 17] of experimental data on influenza virusantibody interactions suggest that there are ~2000 antigenic sites per influenza virus. The mechanism by which antibodies neutralize 6 influenza viruses and, hence, inhibit red cellagglutination [18] is not well understood. The physical closeness of antigenic sites to receptor binding sites and the relatively large sizes of antibodies suggest that bound antibodies may neutralize influenza viruses by occluding receptor binding sites, thereby preventing those sites from binding to cell surface receptors [19, 20] . This "occlusion" mechanism is supported by the 5 A virus can only form one virus-red cell bond with a particular red cell. Since the number of red cells is typically very large (see arguments presented later in the text) it is not necessary to account explicitly for the (negligible) probability that the virus and red cell under consideration are not already bound to each other.
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results of previous experimental studies [7, 21, 22] on antibody-mediated neutralization of influenza viruses. Those experimental results suggest that the fraction of neutralized influenza viruses increases with the average number of bound antibodies per virus in a sigmoidal manner.
The occlusion mechanism described above could be relevant for the neutralization of a number of other viruses, including the human immunodeficiency virus (reviewed in [20] ).
Note that in spite of the high average number of antibodies that were bound to each neutralized influenza virus at the neutralization endpoint [7, 20, 21] , the kinetics of neutralization was apparently first-order [7] . This led to the hypothesis that neutralization may require that a single antibody binds to an antigenic site that is "critical" or "neutralization-relevant" [7] .
According to this hypothesized "critical sites" mechanism, when an antibody binds to a critical antigenic site it may elicit conformational (and other types of) changes to the entire viral surface, and those changes may render receptor binding sites incapable of binding to cell surface receptors [20] . However, there is no documented evidence of such changes to the influenza viral surface induced by antibody binding. Moreover, as has been noted on many occasions (e.g., [23] ), the observed pseudo-first-order kinetics of neutralization could be due to the fact that antibodies were used in excess over influenza viruses in the cited experiments. In light of the paucity of supporting experimental evidence, the critical sites mechanism will not be considered further.
The occlusion mechanism of antibody-mediated neutralization of influenza viruses suggests that the probability of neutralization could be described mathematically by the following equation:
where y is the average number of bound antibodies per virus,  is the average number of bound antibodies per virus at 50% neutralization, and h is the Hill coefficient. For the HC10 antibody used in [7] the Hill coefficient is 3  h [24] . 
At equilibrium, the concentration of virus-red cell bonds found in the ith virus-antibody-red cell mixture is given by:
where
is the equilibrium association constant for virus-red cell binding, that is, the affinity of virus for red cell.
A corresponding equation for the dynamics of the concentration of virus-antibody bonds can be derived using the same principles as those outlined above. Briefly, viruses will collide with antibodies with frequency AV Z [8] . Let n denotes the number of antigenic sites per virus.
The probability that an antigenic site is unoccupied is given by   nV y nV i 
. Meanwhile, the probability that an antibody is free is given by  
. As before, let  denote the probability that during a given collision between virus and antibody the antibody will make contact with a free antigenic site of the virus in the proper orientation. A fraction,
of such properly oriented collisions will result in the formation of a virus-antibody bond, where a Ẽ is the activation energy for virus-antibody bond formation. On the other hand, virus-antibody bonds will dissociate at the rate
Ẽ is the activation energy for dissociation of a virus-antibody bond and f is a pre-exponential factor. Therefore, the dynamics of the concentration of virus-antibody bonds is given by:
Due to the large size of a red cell, each virus-red cell bond would occlude a certain number of antigenic sites on the bound virus. Let us assume that, as in the case of viral neutralization by antibodies, the probability that a given antigenic site is occluded by red cells is an increasing, sigmoidal function of the average occupancy of receptor binding sites, with a maximal probability of 1 0 , 
  
, and a half-maximal average occupancy of 1:
Using (S7) and (S8), the equation for the dynamics of the concentration of virus-antibody bonds becomes:
At equilibrium, the concentration of virus-antibody bonds found in the ith virus-antibody-red cell mixture is given by: 
Mathematical definition of the titer
As noted earlier, the titer of virus X relative to antiserum containing antibodies raised against virus Y (i.e., XY H ) is defined as the reciprocal of the highest dilution of the antiserum that inhibits marked agglutination of red cells by virus X; that is, the ratio of the concentration of antibodies found in undiluted antiserum to the minimum concentration of antibodies that inhibits marked agglutination (see Figure S1 ). If we let l, 1 0 
Now, substituting lBV x e i 2  into (S12) gives:
It follows from (S11) and (S14) that the value of 
, and H depends crucially on the dilution factor used in the HI assay. For greater accuracy the dilution factor should be very close to 1. However, this is impractical for many reasons, including the fact that an astronomical number of antiserum dilutions may be required in order for the HI assay endpoint to be reached.
It is worth drawing attention to an interesting connection between the general mathematical form of the HI equation derived above and the mathematical form of the equation for the neutralization titer. As discussed earlier, the neutralization titer is defined as the reciprocal of the maximum dilution of antiserum raised against virus Y (or the minimum concentration of antibodies) that prevents infection of susceptible cells by virus X in at least 50% of cell cultures inoculated with a sample taken from a mixture of the antiserum and virus X [11] .
Let c be the minimum concentration of free or un-neutralized particles of virus X required to infect at least one cell in 50% of inoculated cell cultures. The dissociation of bonds between antibodies and virus X following inoculation into cell cultures would occur very infrequently since the concentration of virus particles used (and, hence, the maximum possible concentration of antibody-virus bonds) is very low [11] , while 2 K , the dissociation rate of an antibody-virus bond, is typically small. Therefore, viruses that are neutralized prior to inoculation could remain in that state, while un-neutralized viruses would mostly account for subsequent infection of susceptible cells. The neutralization titer can be defined as:
where p, the equilibrium fraction of neutralized viruses, is given by (4), and r is the ratio of infectious to non-infectious viral particles (for influenza viruses, r~.02 [14] ).
It can be seen from both (S4) and (S7) that (S19)
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Using (17) and (18) we find that the neutralization titer is given by the expression:
which has a similar mathematical form as (S16).
Some remarks on the derived HI equation
Recall that in (S16), which quantifies the titer of virus Y relative to virus X-derived antiserum, the parameter V denotes the concentration of virus X, R the concentration of red cells (S16) is used to assess the accuracy of two commonly-used HI-based methods of quantifying the antigenic difference between influenza viruses. First, some observations on the mathematical form of (S16) are in order. Eqn. (S16) makes a number of parameter-free predictions that are intuitive and also consistent with empirical data. Firstly, as expected (e.g., see Tables I & II , and also with the average number of antibodies that must be bound to each particle of virus X in order to neutralize it with a probability of 50% (i.e.,  Therefore, the sensitivity of the HI assay to antigenic differences between influenza viruses could be influenced by the value of r. Below, possible ranges for r are estimated using reasonable values of relevant experimental parameters, providing insight into the potential sensitivity of the HI assay.
Consider the virus-red cell mixture that corresponds to the hemagglutination endpoint (see above) and denote by X Ṽ the concentration of virus particles (i.e., 1 hemagglutinating unit) found in this mixture and by R the concentration of red cells. The virus-red cell mixture contains 0.5ml of a .5% standardized suspension of red cells in a 1ml solution [26] . In the case of chicken red cells, 0.5ml of a .5% standardized chicken red cell suspension contains 7 
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3 red cells [27] . In addition, for influenza viruses that are pre-adapted to red cells (i.e., by means of egg passage), the virus-red cell mixture typically [28, 29] contains approximately as many viruses as red cells 7 . In other words, the concentration of virus particles found in the virus-red cell [31] , for monoclonal antibodies targeted to three HA epitopes of an influenza virus belonging to the H7N1 subtype 8 . Using  . Therefore, the HI assay could be fairly sensitive to antigenic differences between influenza viruses. Indeed, the HI assay can detect immunologically consequential point mutations to individual influenza virus HA epitopes much more accurately than sophisticated methods such as the enzyme-linked immunosorbent assay [30] .
The foregoing discussion suggests that it is reasonable to approximate This suggests that a natural way to decouple the antigenic and non-antigenic contributions to XY H is to transform the titer logarithmically, since the log-transformed titer is additive in the effects of antigenic and non-antigenic variables.
Accuracy of existing measures of antigenic difference
The normalized titer (NHT) of virus X relative to virus Y-derived antiserum is the most commonly-used measure of the antigenic similarity of virus X to virus Y (e.g., [13, 33] ). More specifically, NHT is defined as:
Observe that for a given amount of antigenic difference between X and Y, In contrast to the normalized titer, the AHM of the antigenic difference between viruses X and Y is defined only for cases when both homologous and heterologous titers are available for the two viruses. More precisely, the AHM is given by [36, 37] : . In other words, the AHM is influenced by non antigenic variables to a lesser degree than is the normalized titer; the AHM could afford a more reliable measure of antigenic differences between viruses than the normalized titer. This is consistent with results presented in [38] . The above results suggest that AHM should be preferred over the normalized titer, whenever possible. This could be particularly beneficial when there is significant variation in the non-antigenic properties of the viruses being analyzed. ) depends additively on noise and other non-antigenic contributions. The log-transformed normalized titers corresponding to a particular virus form a vector defined in a space of dimensionality less than or equal to n. Basis vectors for this space can be determined by means of SVD:
where U is an m by m column orthonormal matrix (i.e., The relative contribution of (or the fraction of the variation in titers that is explained by) the ith eigenfactor is given by:
The fraction of the variation explained by a given subset of eigenfactors is the sum of the fraction of the variation explained by the individual eigenfactors. To quantify antigenic differences between viruses, the matrix H of titers is mapped onto the standard coordinate system In the following, two examples are used to illustrate how the above SVD method can enable the delineation of antigenically relevant variation found in titers. First, the method was applied to tables of titers for H3N2 viruses [38] . For each table, the eigenfactors were computed and all subsets of those eigenfactors of sizes ranging from 2 to 5 were determined.
Eigendistances between pairs of viruses were subsequently computed for each eigenfactor subset (see above). The amount of variation explained by each eigenfactors subset was also determined (see above). The antigenic relevance of the variation explained by a particular eigenfactor subset was quantified as the average correlation between eigendistances computed using that subset and the corresponding AHM measure of the antigenic similarity between pairs of viruses. Figure S2a shows a plot of the average correlation versus the explained variation for all eigenfactor subsets and all analyzed tables. The results show that different subsets of eigenfactors can accurately predict AHM, irrespective of the amount of variation they explain ( Figure S2a ). An interesting feature of the results is that the ability to predict AHM increases as the explained variation also increases from 0% to ~40%, and then it drops sharply only to increase again as the explained variation increases above ~60%. The location of the sharp drop corresponds approximately to the average amount of variation explained by the first eigenfactor. This suggests that the variation explained by the first eigenfactor may not be antigenically relevant, in spite of the fact that it is the dominant eigenfactor. In contrast to the above results obtained using un-centered titers, when the titers from each table are mean-centered prior to their analysis, the relationship between the In addition, the SVD method was applied to a row-and column-centered version of a table of titers for 21 viruses belonging to three antigenic subtypes (H1N1, H2N2, and H3N2) of influenza viruses. The goal of this particular application was to determine the effect of meancentering titers on the ability to recover known antigenic relationships between the viruses under consideration. A visual map of the viruses was constructed ( Figure S3a ), as described above. The map allowed the three natural antigenic clusters of the viruses to be accurately recovered using the k-means clustering algorithm [39] . In contrast, when the method was applied to versions of the above table that were either un-centered (Fig. S4b) , only row-centered (Fig. S4c) , or only column-centered (Fig. S3d) , the resulting visual maps did not enable accurate recovery of the natural antigenic clusters of the viruses, suggesting that the proposed mean-centering procedure may be useful indeed. Note that the centered, normalized titers require at least two dimensions to be plotted. Some factors that may influence the number of required dimensions are discussed in Part 3 of this document. The maps were constructed as described above, using a table of titers (H369001) published in [38] . The [42] . In order to accomplish this, an explicit model for the noise structure of eigendistances is assumed. The distribution of the noise associated with eigendistances can be reasonably approximated by the log-normal distribution (e.g., [43] ), which captures the fact that (i) titers are always non-negative, and (ii) they depend on multiplicative stochastic processes, for example, resulting from the serial dilution of sera. In other words, the likelihood of the eigendistances found in the tth HI table under 
where t D denotes a matrix of eigendistances between the viruses found in the tth table, 
where the subscript emphasizes the dependence on k. It follows from (4) that k L attains its maximum value, k L , when  t t t S N log is minimized with respect to X; this also yields the mle for X, which is subsequently mean-centered and transformed to ensure that its columns are mutually orthogonal 9 . k L is used to estimate the optimal value of k, defined as the value of k that 9 If we transform X by setting 
